AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

20/09/2011

VAT status

Active

Bankruptcy proceedings

No proceedings

AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

High

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

26/09/2011

Share capital

5,000.00 PLN

Primary activity

Agents specialised in the sale of particular products or ranges of other products (46.18.Z - PKD 2007)

Representatives

Representatives rights

SPÓŁKĘ REPREZENTUJE DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB CZŁONEK ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE Z PROKURENTEM.

Representatives

Member of the management boardMarcin Tuz

Member of the management boardGilles Marrache

Member of the management boardKrisztian Szabolcs Toka

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
Marcin Tuz	Member of the management board
Gilles Marrache	Member of the management board
Krisztian Szabolcs Toka	Member of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

3,067,233

Net Profit (zł)

3,067,233

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
50,986,758
3,527,486
2,634,980
0.27
5.58
5.17
9,784,056
3,013,398
0
956,215

2023
50,406,162
3,733,048
2,889,811
0.34
9.36
5.73
12,673,867
2,073,867
-
440,684

2024
50,515,472
4,092,622
3,067,233
0.38
3.96
6.07
15,741,100
6,415,155
-
415,067

2024
50,515,472
4,092,622
3,067,233
0.38
3.96
6.07
15,741,100
6,415,155
-
415,067

Turnover (zł)

2024

Turnover (zł)

50,515,472 zł0 % *

Profit before tax (zł)

4,092,622 zł10 % *

Net Profit (zł)

3,067,233 zł6 % *

Working capital requirement (%)

0.38 11.76 % *

Liquidity ratio

3.96 -57.69 % *

Net profitability (%)

6.07 %5.93 % *

Equity (zł)

15,741,100 zł24 % *

Current liabilities (zł)

6,415,155 zł209 % *

Non current liabilities (zł)

Non-current Assets (zł)

415,067 zł-6 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

AMGEN BIOTECHNOLOGIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
11/07/2025	OD 01.01.2024 DO 31.12.2024
21/06/2024	OD 01.01.2023 DO 31.12.2023
06/06/2023	OD 01.01.2022 DO 31.12.2022
26/08/2022	OD 01.01.2021 DO 31.12.2021
28/06/2021	OD 01.01.2020 DO 31.12.2020